Literature DB >> 15616212

A smarter strategy? Reflections on fecal DNA screening for colorectal cancer.

Steven H Woolf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15616212     DOI： 10.1056/NEJMe048259

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Colorectal cancer screening: physicians' knowledge of risk assessment and guidelines, practice, and description of barriers and facilitators.

Authors:  Maida J Sewitch; Pascal Burtin; Martin Dawes; Mark Yaffe; Linda Snell; Mark Roper; Patrizia Zanelli; Alan Pavilanis
Journal:  Can J Gastroenterol       Date:  2006-11       Impact factor: 3.522

2.  Perspectives on the treatment of colorectal carcinoma.

Authors:  Ren Zhao; Jing Li
Journal:  World J Gastrointest Oncol       Date:  2010-05-15

3.  Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.

Authors:  Ji-Gui Chen; Juan Cai; Huan-Lei Wu; Hua Xu; Yu-Xing Zhang; Chao Chen; Qian Wang; Jun Xu; Xiang-Lin Yuan
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

4.  Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer.

Authors:  Heather P Ostendorff; Amany Awad; Karen I Braunschweiger; Ziying Liu; Zhi Wan; Kenneth J Rothschild; Mark J Lim
Journal:  J Immunol Methods       Date:  2013-10-24       Impact factor: 2.303

Review 5.  Implications of new colorectal cancer screening technologies for primary care practice.

Authors:  Ann G Zauber; Theodore R Levin; C Carl Jaffe; Barbara A Galen; David F Ransohoff; Martin L Brown
Journal:  Med Care       Date:  2008-09       Impact factor: 2.983

6.  Sources of bias in specimens for research about molecular markers for cancer.

Authors:  David F Ransohoff; Margaret L Gourlay
Journal:  J Clin Oncol       Date:  2009-12-28       Impact factor: 44.544
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.